Access to Mayo's patient data solves the single biggest bottleneck in clinical AI development: getting enough high-quality, diverse clinical data to train and validate models
Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Another new report confirms small excess risk of GLP-1 drugs for NAION, a vision-threatening condition (acronym for nonarteritic anterior ischemic optic neuropathy) acpjournals.org/doi/epdf/10.73 Thanks @EricTopol
Whether you are recovering from physical strain, dealing with ongoing discomfort, or simply exploring innovative wellness therapies, BPC-157 injections may help support your bodys healing and recovery process
Side effect risk depends on your health history, dosage, treatment plan, and provider monitoring
My protocol was straightforward: 1.5 mg subcutaneous injection each morning before breakfast, rotating injection sites between my abdomen and outer thigh